

Holly Drugs Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 17 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.50 M
- Revenue Growth 27.77%
- Profit Growth -25.78%
- Ebitda 9.51%
- Net Worth 8.44%
- Total Assets 7.95%
About Holly Drugs
Holly Drugs Private Limited (HDPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 18 July 2007 and has a history of 17 years and seven months. Its registered office is in Chandigarh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.50 M.
Deepak Batra and Sahil Batra serve as directors at the Company.
Company Details
- Location
Chandigarh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24232CH2007PTC030879
- Company No.
030879
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jul 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Holly Drugs?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Deepak Batra ![]() | Director | 18-Jul-2007 | Current |
Sahil Batra ![]() | Director | 25-Mar-2018 | Current |
Financial Performance of Holly Drugs.
Holly Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27.77% increase. The company also saw a substantial fall in profitability, with a 25.78% decrease in profit. The company's net worth moved up by a moderate rise of 8.44%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Holly Drugs?
In 2022, Holly Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹6.50 M
₹0
Charges Breakdown by Lending Institutions
- Indian Bank : 0.40 Cr
- State Of India : 0.25 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
24 Aug 2013 | Indian Bank | ₹4.00 M | Open |
26 Nov 2007 | State Of India | ₹2.50 M | Open |
How Many Employees Work at Holly Drugs?
Unlock and access historical data on people associated with Holly Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Holly Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Holly Drugs's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Holly Drugs
Recent activity within the organization
- Annual General Meeting
Holly Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Balance Sheet
Holly Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Chandigarh.
- Director Appointment
Sahil Batra was appointed as a Director was appointed as a Director on 25 Mar 2018 & has been associated with this company since 6 years 11 months .
- Charges
A charge with Indian Bank amounted to Rs. 4.00 M with Charge ID 10454303 was registered on 24 Aug 2013.
- Charges
A charge with State Of India amounted to Rs. 2.50 M with Charge ID 10084974 was registered on 26 Nov 2007.
- Director Appointment
Deepak Batra was appointed as a Director was appointed as a Director on 18 Jul 2007 & has been associated with this company since 17 years 7 months .
Frequently asked questions
What is the Incorporation or founding date of Holly Drugs Private Limited?
Holly Drugs Private Limited was incorporated on 18 Jul 2007.
What is authorized share capital and paid-up capital of Holly Drugs Private Limited?
The authorized share capital of Holly Drugs Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Holly Drugs Private Limited?
Currently 2 directors are associated with Holly Drugs Private Limited.
- Deepak Batra
- Sahil Batra
What is the registered address of Holly Drugs Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Holly Drugs Private Limited is Sco 392, 2Nd Floor Sector 37D India, Chandigarh, 160036.
What is the corporate identification number (CIN) and company number of Holly Drugs Private Limited?
The corporate identification number (CIN) of Holly Drugs Private Limited is U24232CH2007PTC030879 and the company number is 030879 as per Ministry of Corporate Affairs (MCA).
What is the official website of Holly Drugs Private Limited?
The Official website of Holly Drugs Private Limited is https://www.holly-drugs-pvt-ltd.business.site
What has been the recent revenue trend for Holly Drugs Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Holly Drugs Private Limited has risen by 27.77%.
What change has been observed in the net worth of Holly Drugs Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Holly Drugs Private Limited has experienced an upsurge of 8.44%.
What are the total open charges for Holly Drugs Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Holly Drugs Private Limited amount to ₹ 6.50 M.
When was the last Balance Sheet of Holly Drugs Private Limited filed with the ROC?
The most recent Balance Sheet for Holly Drugs Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
SB
Sandeep BatraDirector